Business
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral blood samples from patients living with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and giant cell arteritis (GCA) to uncover immune signatures associated with disease activity, flare, remission and therapeutic response.
About this update from 10x Genomics, Inc.
[{"type":"text","content":"Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care ","length":120,"tagName":"p","attribs":{}},{"type":"text","content":"PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral blood samples from patients living with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and giant cell arteritis (GCA) to uncover immune signatures associated with disease activity, flare, remission and therapeutic response.","length":501,"tagName":"p"},{"type":"image","alt":"10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)","displaySize":"","headline":null,"caption":"10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/0862b7da135f6592c758a7fd225e5c41"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ngkNiIWWETdTothBh84MZg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM1MztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0862b7da135f6592c758a7fd225e5c41","width":400,"height":200}},"href":"https://mma.prnewswire.com/media/1700607/10x_Genomics_Logo_V1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The study will be led by investigators Kevin Wei, MD, PhD, Jeffrey Sparks, MD, MMSc, Deepak Rao, MD, PhD, Paul Hoover, MD, PhD and Abigail Schiff, MD, PhD, all from the Division of Rheumatology, Inflammation and Immunity at Brigham and Women's Hospital, founding member of Mass General Brigham.","length":298,"tagName":"p"},{"type":"text","content":"Autoimmune diseases remain among the most challenging conditions to diagnose and treat. Standard clinical tests provide only limited insight into the complex immune processes underlying these diseases and may be confounded by unrelated inflammation or masked by certain therapies. This level of uncertainty has led some experts to describe autoimmune disease management as a clinical 'random walk,' driven more by symptoms, nonspecific tests and experience, rather than by direct measures of immune activity, leaving clinicians without reliable tools to guide long-term care.",...